scleroderma的例句大全

Acute kidney injury of systemic sclerosis: scleroderma renal crisis and crescentic glomerulonephritis

系统性硬化并发急性肾损伤的临床病理分析

Visceral damage: in heart, lung lesions mainly accounted for60%, digestive system and heart, lung damage in diffuse cutaneous scleroderma and acral scleroderma in the distribution of no statistical significance.

内脏损害：以心、肺病变为主占60%，消化系统及心、肺的损害在弥漫皮肤型硬皮病及肢端型硬皮病中的分布无统计学意义。

Necrobiosis lipoidica ( NL) is a dermal connective tissue-involved disease characterized by scleroderma-like patches in the pretibial area.

类脂质渐进性坏死是发生在真皮结缔组织的疾病，以小腿胫前的硬皮病样斑块为临床特征。

Anti ScL 70 antibody has been used as a diagnostic marker of systemic scleroderma. ScL 70 is DNA topoisomerase ⅰ.

系统性硬化病是一种自身免疫病，抗ScL70抗体是该病的标记性抗体，其抗原ScL70就是DNA拓扑异构酶Ⅰ。

Connective tissue disease ( CTD) includes many diseases. For instance, lupus erythematosus, scleroderma, rheumatoid arthritis, sjogren syndrome, dermatomyositis/ multiple myositis and vasculitis.

结缔组织病（CTD）包括许多种疾病，如红斑狼疮、硬皮病、类风湿关节炎、干燥综合征、皮肌炎/多发性肌炎及血管炎等。

There was no cross reaction in the sera from 72 patients with dermatomyositis or polymyositis ( DM/ PM), from 48 patients with progressed systemic scleroderma ( PSS), and from 78 patients with mixed connective tissue disease ( MCTD).

对皮肌炎和多发性肌炎（DM/PM）72份、硬皮病（PSS）48份和混合性结缔组织病（MCTD）78份血清亦无交叉反应出现。

It often affects various internal organs, such as lung, heart, kidney, and digestive tract, leading to severe complications such as pulmonary interstitial fibrosis and pulmonary hypertension. Ten-year survival rate of scleroderma is60%~ 90%.

此外，还可累及肺脏、心脏、肾脏、消化道等内脏器官，导致肺间质纤维化、肺动脉高压等严重并发症，10年生存率约为60%～90%。

detection of anti-scl-70 antibody and its clinical significance in patients with systemic scleroderma

系统性硬皮病患者抗Scl-70抗体的测定及临床意义

effects of salvia miltiorrhiza bunge on the proliferation and collagen synthesis in systemic scleroderma skin fibroblasts

丹参对系统性硬皮病患者皮肤成纤维细胞增殖和胶原合成的影响

clinical observation on effect of yang-warming and blood-stasis-removing therapy for systemic scleroderma

温阳化瘀法治疗系统性硬皮病的临床观察

bone density in premenopausal women with systemic scleroderma

系统性硬皮病妇女骨密度测定的探讨

the progress of treatment of systemic scleroderma with vasoactive drugs

血管活性药物治疗系统性硬皮病的进展

clinical study on wubi capsule for treatment of 33 cases of systemic scleroderma

五痹胶囊治疗系统性硬皮病33例临床研究

clinical associations based on serum anti-ena polypeptide antibodies in patients with systemic scleroderma

系统性硬皮病患者血清ENA多肽抗体与临床的关系

scleroderma(or progressive systemic sclerosis): chronic disease that hardens the skin and fixes it to underlying structures.

硬皮病（亦称进行性全身硬化症）：一种使皮肤变硬并固着于皮下结构的慢性皮肤病。

esophageal motility problems can occur in patients with progressive systemic sclerosis (scleroderma) because the submucosa becomes fibrotic.

系统性硬化（硬皮病）病人食管蠕动障碍，因为黏膜下层纤维化。更详细。

Objective To explore the effect of Antisclerosis Composite Prescription ACP and penicillamine on scleroderma mouse.

目的探讨抗硬化复方与青霉胺对硬皮病小鼠模型的影响.

It discussed the preparing method of chromosome of Scleroderma sichuanensis ( Hymenoptera : Bethylidae Sclerderma )

对川硬皮肿腿蜂SclerodermasichuanensisXiao ( Hymenoptera:bethylidaeSclerderma ) 染色体制备方法进行了探讨,结果表明.

Autoimmune diseases and collagen diseases, such as systemic lupus erythematosus, dermatomyositis, scleroderma, and so on.

自身免疫性疾病及胶原性疾病, 如系统性红斑狼疮 、 皮肌炎 、 硬皮病等.

Systemic Scleroderma is also known as Systemic Sclerosis.

系统性硬皮病也看作系统性硬化症.